The evidence for the safety of thiomersal in newborn and infant vaccines

Vaccine

Volumn 22, Issue 15-16, 2004, Pages 1854-1861

  Clements, C John ^a  

^a BURNET INSTITUTE   (Australia)

Author keywords

Hepatitis B; Mercury; Thiomersal

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; THIOMERSAL;

ARTICLE; BCG VACCINATION; BLOOD BRAIN BARRIER; BODY MASS; BRAIN; DIPHTHERIA; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG SAFETY; HEPATITIS B; HUMAN; INFANT; INFLUENZA; LOW BIRTH WEIGHT; MEASLES; NEWBORN; PERTUSSIS; POLIOMYELITIS; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TETANUS; THEORETICAL STUDY; VACCINATION;

ADULT; ANIMALS; ETHYLMERCURY COMPOUNDS; FEMALE; FISHES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; METHYLMERCURY COMPOUNDS; PREGNANCY; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL; VACCINES;

EID: 2342589510     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.017     Document Type: Article

References (48)

1. Grandjean P., Weihe P., White R., Debes F., Araki S., Yokoyama K., et al. Cognitive deficit in 7-year-old children with prenatal exposure to methyl mercury. Neurotoxicol. Teratol. 19(6):1997;417-428
2. US Pharmacopeia 24. Rockville (MD): US Pharmacopeial Convention; 1999. p. 1644.
3. Bernier R.H., Frank J.A., Nolan T.F. Abscesses complicating DTP vaccination. Am. J. Dis. Child. 135:1981;826-828
4. Simon P.A., Chen R.T., Elliot J.A., Schwartz B. Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccine. Pediatr. Infect. Dis. J. 12:1993;368-371
5. Harada Y. Congenital (or fetal) minamata disease. In: Study Group of Minamata Disease Editors. Minamata disease. Japan Kumamoto University; 1968. p. 93-118.
6. Bakir F., Damlugi S.F., Amin-Zaki L., Murtadha M., Khalidi A., Al-Rawi N.Y., et al. Methylmercury poisoning in Iraq. Science. 181:1973;230-241
7. World Health Organization. International Programme on Chemical Safety. Environmental Health Criteria 101 Methylmercury. Geneva (Switzerland): World Health Organization; 1990.
8. Lucier G, Boyer R. Report of the Workshop Proceedings of Conference Organized by Committee on Environment and Natural Resouces. Office and Science and Technology Policy, National Institute of Environmental Health Sciences, The White House; November 18-20, 1998.
9. Harada M. Minamata disease: methyl mercury poisoning in Japan caused by environmental pollution. Crit. Rev. Toxicol. 25:1995;1-24
10. Choi B.H., Lapham L.W., Amin-Zaki L., Saleem T. Abnormal neuronal migration deranged cerebral cortical organization and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmercury poisoning in utero. J. Neuropathol. Exp. Neurol. 87(6):1978;719-733
11. Mahaffey KR, Rice GE. A assessment of exposure to mercury in the United States: Mercury Study Report to Congress. Washington, DC: US Environmental Protection Agency; 1997. Document EPA-452/R-97-006.
12. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for mercury. Atlanta (GA); 1999.
13. Action level for mercury in fish, shellfish, crustaceans, and other aquatic animals. US: Department of Health, Education, and Welfare, Food and Drug Administration; January 19, 1979. Federal Register 443990.
14. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ 1986;64:929-41.
15. Core information for the development of immunization policy. Department of Vaccines and Biologicals. Geneva: World Health Organization; 2002. WHO/V&B/02.28. http://www.who.int/vaccines-documents/DocsPDF01/www573.pdf.
16. Clements C.J., Ball L.K., Ball R., Pratt D. Thiomersal in vaccines (correspondence). Lancet. 355:2000;1279-1280
17. Clarkson TW. The pharmacology of mercury compounds. Ann Rev Pharmacol 1972;375-406.
18. Cox NH, Forsyth A. Thimerosal allergy and vaccination reactions. Contact Dermat 1988;229-33.
19. Axton J.M.H. Six cases of poisoning after a parenteral organic mercurial compound (merthiolate). Postgrad. Med. J. 48:1972;417-421
20. Fagan D.G., Pritchard J.S., Clarkson T.W., Greenwood M.R. Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. Arch. Dis. Child. 52:1977;962-964
21. Matheson D.S., Clarkson T.W., Gelfand E.W. Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin. J. Pediatr. 97:1980;153-155. Toxicological profile for mercury. Atlanta (GA): Agency for Toxic Substances and Disease Registry (ATSDR); 1999
22. Rohyans J., Walson P.D., Wood G.A., MacDonald W.A. Mercury toxicity following merthiolate ear irrigations. J. Pediatr. 104:1994;311-313
23. Pfab R., Muckter H., Roider G., Zilker T. Clinical course of severe poisoning with thiomersal. Clin. Toxicol. 34:1996;453-460
24. Davidson P.W., Myers G.J., Cox C., Axtell C., Shamlaye C., Sloane-Reeves J., et al. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA. 280(8):1998;701-707
25. Kjellstrom T, Kennedy P, Wallis S, Mantell C. Physical and mental development of children with prenatal exposure to mercury from fish. Stage I: Preliminary tests at age 4. Solna (Sweden): National Swedish Environmental Protection Board; 1986. Report 3080.
26. Grandjean P., Weihe P., White R.F., Debes F. Cognitive performance of children prenatally exposed to "safe" levels of methyl mercury. Environ. Res. 77:1998;165-172
27. Jacobson J.L. Contending with contradictory data in a risk assessment context: the case of methylmercury. J. Neurotoxicol. 22:2001;667-675
28. Davidson PW, Myers GJ, Cox C, Shamlaye CF, Clarkson TW. The Seychelles child development study: background, design and results through 66 months of age. In: Proceedings of the Sixth International Conference on Mercury as a Global Polutant, Minamata, Japan; October 15-19, 2001.
29. Myers GJ, Davidson PW, Palumbo D, Cox C, Shamlaye CF, Clarkson TW. The Seychelles child development study: testing and results at 107 months of age. In: Proceedings of the Sixth International Conference on Mercury as a Global Polutant, Minamata, Japan; October 15-19, 2001.
30. Juhlshamn K., Andersen A., Ringsdal O., Morkore J. Trace elements in the Faroe Islands. I. Element levels in edible parts of pilot whales (Globicephalus meleanus). Sci. Total Environ. 65:1987;53-62
31. Toxicological effects of methylmercury. National Research Council, Committee on the Toxicological Effects of Methylmercury. Washington, DC: National Academy Press; 2000.
32. NIEHS Expert Group (1998). Scientific issues relevant to assessment of health effects from exposure to methyl mercury. Report on Workshop Organized by Committee on Environment & Natural Resources and Office of Science and Technology Policy, The White House; November 18-20, 1998.
33. Mitchell JW, Kjellstrom TE, Reeves RL. Mercury in take-away fish in New Zealand. New Zealand Med J 1982;112-114.
34. Nelson K.B., Bauman M.L. Thiomersal and autism? Pediatrics. 111:2003;674-679
35. Verstraeten T. Assessment of neurologic and renal impairment associated with thimerosal-containing vaccines. Presentation at the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Atlanta, GA; June 21, 2000.
36. National Academies of Sciences. EPA's methylmercury guideline is scientifically justifiable for protecting most Americans, but some may be at risk. Press release: July 11, 2000. Available from URL: http//www4. nationalacademies.org/nes.nsf/isbn/0309071402?OpenDocument.
37. Immunization safety review. Thimerosol-containing vaccines and neurodevelopmental disorders. Immunization Safety Review Committee. Board of Health Promotion and Disease Prevention, Institute of Medicine. Washington, DC: National Academy Press; 2001.
38. Andrews N, Miller E, Grant A, Stowe J, Osbourne V, Taylor B. Thiomersal exposure in infants and developmental disorders: a retrospective cohort study does not support a causal association. Br Med J, in press.
39. Heron J, Golding J, the ALSPAC Team. Thiomersal and childhood behaviour and development: a birth cohort study. Am J Epidemiol, in press.
40. Statement from the Committee on Safety of Medicines (UK); February 21, 2003. Further data support safety of thiomersal in vaccines (http://www.mca.gov. uk/whatsnew/thiomersalstatement_210203.pdf), accessed: September 18, 2003.
41. Magos L., Brown A.W., Sparrow S., Bailey E., Snowden R.T., Skipp W.R. The comparative toxicology of ethyl and methyl mercury. Arch. Toxicol. 57:1985;260-267
42. Magos L. Review on the toxicity of ethyl mercury including its presence as a preservative in biological and pharmaceutical products. J. Appl. Toxicol. 21:2001;1-5
43. Pichichero M.E., Cernichiari E., Lopreiato J., Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet. 360:2002;1737-1741
44. Ma X, Does M, Buffler PA, Wiencke JK. Hepatitis B vaccination and the risk of childhood leukaemia. American Association for Cancer Research Annual Meeting, San Francisco; April 2002 [poster session abstract 3801].
45. Dockerty J.D., Skegg D.C.G., Elwood J.M., Herbison G.P., Becroft D.M.O., Lewis M.E. Infections, vaccinations, and the risk of childhood leukaemia. Br. J. Cancer. 80:1999;1483-1489
46. Schuz J., Kaletsch U., Meinert R., Kaatsch P., Michaelis J. Association of childhood leukaemia with factors related to the immune system. Br. J. Cancer. 80:1999;585-590
47. Stajich G.V., Lopez G.P., Harry S.W., Sexson W.R. Iatrogenic exposure to mercury after hepatitis B vaccination in pre-term infants. J. Pediatr. 136:2000;679-681
48. Yoshida M., Ohata H., Yamauchi Y., Seki Y., Sagi M., Yamazaki K., et al. Age-dependent changes in metallothionein levels in liver and kidney of the Japanese. Biol. Trace Elem. Res. 65:1998;167-173